Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia
Creators
- Yuan Liang Woon1
- Yee Leng Lee2
- Yoong Min Chong3
- Nor Aliya Ayub4
- Swarna Lata Krishnabahawan2
- June Fei Wen Lau1
- Ramani Subramaniam-Kalianan1
- I-Ching Sam3
- Yoke Fun Chan3
- Raj Kumar Sevalingam4
- Azura Ramli4
- Chuan Huan Chuah5
- Hani Mat-Hussin6
- Chee Loon-Leong7
- Suresh Kumar Chidambaram5
- Kalaiarasu M. Peariasamy8
- Pik Pin Goh8
- 1. Center for Clinical Epidemiology, Institute for Clinical Research, National Institutes of Health, Ministry of Health, Malaysia
- 2. Clinical Research Center, Sungai Buloh Hospital, Ministry of Health, Malaysia
- 3. Department of Medical Microbiology, Faculty of Medicine, University Malaya, Malaysia
- 4. Clinical Research Center, Kuala Lumpur Hospital, Ministry of Health, Malaysia
- 5. Infectious Disease Unit, Medical Department, Sungai Buloh Hospital, Ministry of Health, Malaysia
- 6. National Public Health Laboratory, Ministry of Health, Malaysia
- 7. Infectious Disease Unit, Medical Department, Kuala Lumpur Hospital, Ministry of Health, Malaysia
- 8. Institute for Clinical Research, National Institutes of Health, Ministry of Health, Malaysia
Description
Background Asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections are well documented. Healthcare workers (HCW) are at increased risk of infection due to occupational exposure to infected patients. We aim to determine the prevalence of SARS-CoV-2 antibodies among HCW who did not come to medical attention.
Methods We prospectively recruited 400 HCW from the National Public Health Laboratory and two COVID-19 designated public hospitals in Klang Valley, Malaysia between 13/4/2020 and 12/5/2020. Quota sampling was used to ensure representativeness of HCW involved in direct and indirect patient care. All participants answered a self-administered questionnaire and blood samples were taken to test for SARS-CoV-2 antibodies by surrogate virus neutralization test.
Findings The study population comprised 154 (38.5%) nurses, 103 (25.8%) medical doctors, 47 (11.8%) laboratory technologists and others (23.9%). A majority (68.9%) reported exposure to SARS-CoV-2 in the past month within their respective workplaces. Adherence to personal protection equipment (PPE) guidelines and hand hygiene were good, ranging from 91-100% compliance. None (95% CI: 0, 0.0095) of the participants had SARS-CoV-2 antibodies detected, despite 182 (45.5%) reporting some symptoms one month prior to study recruitment. One hundred and fifteen (29%) of participants claimed to have had contact with known COVID-19 persons outside of their workplace.
Interpretation Zero seroprevalence among HCW suggests a low incidence of undiagnosed COVID-19 infection in our healthcare setting during the first local wave of SARS-CoV-2 infection. The occupational risk of SARS-CoV-2 transmission within healthcare facilities can be prevented by adherence to infection control measures and appropriate use of PPE.
Files
1-s2.0-S2666606521000328-main.pdf
Files
(1.4 MB)
Name | Size | Download all |
---|---|---|
md5:d730cfb6cafe1c439e1ca87bbf25e34c
|
1.4 MB | Preview Download |